Header Logo

Jennifer LaFemina

Concepts (163)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
11
2017
273
2.270
Why?
Internship and Residency
5
2022
578
1.930
Why?
Carcinoma, Pancreatic Ductal
7
2015
64
1.260
Why?
Pancreatectomy
5
2016
83
1.140
Why?
Education, Medical, Graduate
3
2022
232
0.920
Why?
Social Media
1
2021
95
0.770
Why?
Mastectomy
1
2019
51
0.730
Why?
General Surgery
1
2020
118
0.730
Why?
Pancreatitis
2
2009
81
0.720
Why?
Databases, Factual
2
2019
721
0.710
Why?
Venous Thrombosis
1
2019
102
0.690
Why?
Students, Medical
1
2020
224
0.690
Why?
Exocrine Pancreatic Insufficiency
1
2016
7
0.620
Why?
Pancreas, Exocrine
1
2016
11
0.610
Why?
Hemangioma
1
2016
24
0.610
Why?
Pancreatitis, Chronic
1
2015
18
0.590
Why?
Pancreaticoduodenectomy
1
2016
38
0.590
Why?
Genetic Testing
1
2015
112
0.560
Why?
Breast Neoplasms
2
2021
984
0.550
Why?
Postoperative Complications
2
2019
882
0.540
Why?
Islets of Langerhans
1
2016
255
0.540
Why?
Carcinoma, Renal Cell
1
2016
123
0.520
Why?
Adenocarcinoma, Mucinous
4
2015
24
0.510
Why?
Kidney Neoplasms
1
2016
166
0.510
Why?
Liver Neoplasms
1
2016
235
0.500
Why?
Nerve Sheath Neoplasms
1
2012
2
0.490
Why?
Retrospective Studies
11
2019
4384
0.490
Why?
Neurofibromatosis 1
1
2012
16
0.480
Why?
Neoplasms, Radiation-Induced
1
2012
26
0.480
Why?
Adrenal Cortex Neoplasms
1
2012
2
0.480
Why?
Stomach
1
2010
56
0.400
Why?
Carcinoma, Papillary
3
2015
35
0.400
Why?
Humans
25
2022
48426
0.390
Why?
Suture Techniques
1
2010
71
0.390
Why?
Pancreas
1
2010
139
0.390
Why?
Hospital Units
1
2008
9
0.370
Why?
Gallstones
1
2008
18
0.370
Why?
Hospital Costs
1
2008
96
0.340
Why?
Risk Factors
5
2019
4182
0.340
Why?
Follow-Up Studies
5
2019
1925
0.330
Why?
Middle Aged
12
2019
13427
0.320
Why?
Patient Admission
1
2008
162
0.320
Why?
Female
16
2022
26167
0.300
Why?
Clinical Competence
2
2020
533
0.290
Why?
Radiotherapy, Adjuvant
2
2016
54
0.270
Why?
Chemotherapy, Adjuvant
2
2016
76
0.270
Why?
Aged, 80 and over
6
2016
4204
0.250
Why?
Preoperative Care
3
2019
141
0.240
Why?
Male
15
2022
23088
0.240
Why?
Prognosis
4
2019
1244
0.230
Why?
Aged
10
2017
10783
0.220
Why?
Treatment Outcome
5
2017
3804
0.220
Why?
Burnout, Professional
1
2022
76
0.220
Why?
Neoplasm Recurrence, Local
2
2013
235
0.220
Why?
Canada
1
2020
104
0.210
Why?
Statistics, Nonparametric
2
2012
184
0.200
Why?
Inservice Training
1
2020
76
0.200
Why?
Multivariate Analysis
3
2013
854
0.200
Why?
Surgical Oncology
1
2019
4
0.200
Why?
Young Adult
3
2016
3600
0.190
Why?
Certification
1
2019
36
0.190
Why?
Adult
8
2022
13163
0.190
Why?
Learning
1
2020
125
0.190
Why?
Postoperative Hemorrhage
1
2019
28
0.180
Why?
Education, Medical, Continuing
1
2019
104
0.180
Why?
Hepatectomy
1
2019
43
0.180
Why?
Cross-Sectional Studies
2
2022
2022
0.180
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2017
12
0.180
Why?
Carcinoma, Neuroendocrine
1
2017
11
0.180
Why?
Mutation
4
2015
2224
0.170
Why?
Kaplan-Meier Estimate
3
2015
354
0.170
Why?
Pandemics
1
2021
352
0.170
Why?
Lymphoscintigraphy
1
2016
4
0.160
Why?
Sentinel Lymph Node
1
2016
8
0.160
Why?
Curriculum
1
2020
474
0.160
Why?
Methylene Blue
1
2016
22
0.160
Why?
Sentinel Lymph Node Biopsy
1
2016
34
0.160
Why?
Coloring Agents
1
2016
51
0.160
Why?
Neoplasm, Residual
2
2013
33
0.150
Why?
United States
4
2022
6082
0.150
Why?
GTP-Binding Protein alpha Subunits, Gs
1
2015
11
0.140
Why?
Quality Improvement
1
2019
320
0.140
Why?
Multidetector Computed Tomography
1
2014
19
0.140
Why?
ras Proteins
1
2015
77
0.140
Why?
Time Factors
3
2019
3189
0.140
Why?
Diet
1
2019
595
0.130
Why?
Hypoglycemic Agents
1
2016
190
0.130
Why?
Nomograms
1
2013
15
0.130
Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2013
3
0.130
Why?
Early Detection of Cancer
1
2015
174
0.130
Why?
Cohort Studies
2
2010
2043
0.130
Why?
Melanoma
1
2016
282
0.130
Why?
Carcinoma in Situ
1
2013
31
0.130
Why?
Proto-Oncogene Proteins
1
2015
301
0.120
Why?
Genetic Predisposition to Disease
1
2015
575
0.120
Why?
Neoadjuvant Therapy
1
2012
53
0.120
Why?
Confidence Intervals
1
2012
257
0.110
Why?
Neoplasm Metastasis
1
2012
202
0.110
Why?
Skin Neoplasms
1
2016
366
0.110
Why?
Biomarkers, Tumor
1
2015
426
0.110
Why?
Adolescent
2
2012
5292
0.110
Why?
Health Care Costs
1
2012
151
0.100
Why?
Proportional Hazards Models
1
2012
632
0.100
Why?
Pancreatic Fistula
1
2010
5
0.100
Why?
Adenocarcinoma, Papillary
1
2010
6
0.100
Why?
Survival Rate
1
2012
664
0.100
Why?
Neoplasms
1
2019
986
0.100
Why?
Anastomosis, Surgical
1
2010
71
0.100
Why?
Carrier State
1
2009
18
0.100
Why?
Siblings
1
2009
38
0.100
Why?
Logistic Models
2
2013
1168
0.090
Why?
Pedigree
1
2009
167
0.090
Why?
Cholangiography
1
2008
34
0.090
Why?
Medicare
1
2012
434
0.090
Why?
Cholecystectomy
1
2008
34
0.090
Why?
Cholangiopancreatography, Endoscopic Retrograde
1
2008
35
0.090
Why?
Tobacco
1
2009
86
0.090
Why?
Family
1
2009
191
0.080
Why?
Linear Models
1
2008
409
0.080
Why?
Cost-Benefit Analysis
1
2008
229
0.080
Why?
Alcohol Drinking
1
2009
264
0.080
Why?
Risk Assessment
2
2013
1573
0.080
Why?
Cell Line, Tumor
1
2010
1261
0.080
Why?
Quality Indicators, Health Care
1
2008
312
0.070
Why?
Patient Readmission
1
2008
347
0.070
Why?
Disease Models, Animal
1
2010
1809
0.060
Why?
Tomography, X-Ray Computed
1
2009
1057
0.060
Why?
Proto-Oncogene Proteins p21(ras)
2
2015
50
0.060
Why?
New England
1
2022
241
0.060
Why?
Personnel Selection
1
2022
41
0.060
Why?
Mastectomy, Segmental
1
2021
38
0.050
Why?
Students
1
2022
191
0.050
Why?
Mammography
1
2021
229
0.050
Why?
Neoplasm Grading
1
2017
67
0.040
Why?
Ki-67 Antigen
1
2017
29
0.040
Why?
Mice
1
2010
9151
0.040
Why?
Lymphatic Metastasis
1
2016
59
0.040
Why?
Incidence
1
2019
1110
0.040
Why?
Chromogranins
1
2015
11
0.040
Why?
Oncogene Proteins
1
2015
43
0.030
Why?
Surveys and Questionnaires
1
2022
2236
0.030
Why?
Body Mass Index
1
2019
854
0.030
Why?
Observer Variation
1
2014
175
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2015
246
0.030
Why?
Ubiquitin-Protein Ligases
1
2015
190
0.030
Why?
Neoplasm Invasiveness
1
2013
203
0.030
Why?
Chi-Square Distribution
1
2013
401
0.030
Why?
Neoplasm Staging
1
2013
371
0.030
Why?
SEER Program
1
2012
68
0.030
Why?
Diagnosis, Differential
1
2014
768
0.030
Why?
Disease Progression
1
2015
706
0.030
Why?
Sensitivity and Specificity
1
2014
943
0.030
Why?
Health Services
1
2012
84
0.030
Why?
Population Surveillance
1
2012
208
0.030
Why?
Veratrum Alkaloids
1
2010
10
0.030
Why?
Reproducibility of Results
1
2014
1311
0.030
Why?
Genes, Tumor Suppressor
1
2010
79
0.020
Why?
Xenograft Model Antitumor Assays
1
2010
165
0.020
Why?
Hedgehog Proteins
1
2010
111
0.020
Why?
DNA-Binding Proteins
1
2015
1122
0.020
Why?
Prospective Studies
1
2013
2473
0.020
Why?
Hospitalization
1
2012
1062
0.020
Why?
Animals
1
2010
18037
0.010
Why?
LaFemina's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (163)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_